Snowball logo
logo
0239_logo

Daihan Pharmaceutical Co.Ltd

023910 KQ
26,950.00-50.00  (0.19%)
Estimate
Beta
0.166
Growth
Revenue, YoY
5.66%
Net income, YoY
-8.7%
FCF, YoY
71.69%
Forecast
P/E (FWD)
4.6
EPS (FWD)
5,814
Dividends
Dividend yield
3.71%
Annual payout
1,000.00
Next ex. div date
December 29, 26
Payout
18.79%
Div.growth, 5y
20.11%
Dividend growth streak
4 y
Div.rating
About the company
Ticker
023910
ISIN
KR7023910003
Country
South Korea
Sector (GICS)
Energy
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.

Frequently asked questions

What sector does Daihan Pharmaceutical Co.Ltd (023910) operate in?

Daihan Pharmaceutical Co.Ltd belongs to the Energy sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Daihan Pharmaceutical Co.Ltd (023910) current stock price?

As of the latest data, Daihan Pharmaceutical Co.Ltd stock price is ₩26,950, with a previous close of ₩27,000. Daihan Pharmaceutical Co.Ltd lost -₩50 in the last trading session, representing a -0.19% loss.

What is Daihan Pharmaceutical Co.Ltd (023910) current market capitalization?

Daihan Pharmaceutical Co.Ltd market cap is approximately 158.47 billion.

Does Daihan Pharmaceutical Co.Ltd (023910) pay dividends?

Yes. Daihan Pharmaceutical Co.Ltd pays annual dividends with an annualized yield of 3.71% and an estimated annual payout of ₩1,000 per share.

When is the next ex-dividend date for Daihan Pharmaceutical Co.Ltd (023910)?

The next ex-dividend date is scheduled for December 29, 2026.

What is Daihan Pharmaceutical Co.Ltd (023910) beta (volatility) score?

Daihan Pharmaceutical Co.Ltd has a beta of 0.166, indicating lower volatility than the overall market.